Vaccine Info

TIV High Dose Influenza Vaccine

Authored by
Fact checked by
Robert Carlson, MD

TIV High Dose Description

TIV High Dose  Influenza Vaccine contains the following inactive viruses for the 2019-2020 season:

  • A/Brisbane/02/2018 (H1N1)pdm09 - like strain (A/Brisbane/02/2018 IVR-190)
  • A/Kansas/14/2017 (H3N2) - like strain (A/Kansas/14/2017 NYMC X-327)
  • B/Colorado/06/2017 - like strain (B/Maryland/15/2016 NYMC BX-69A

TIV High Dose Indication

TIV High Dose is indicated for active immunization of people 65 years of age and older against influenza disease in the UK.

TIV High Dose Vaccine Dosage

Immune defenses naturally decline with advancing age, which can cause immune responses to vaccines to diminish. 

This natural decline also means that older adults are particularly vulnerable to influenza infection and its complications. 

TIV High Dose has therefore been designed specifically to improve protection against influenza compared to standard dose TIV for this senior population.

Clinical Trials

No clinical trials found